Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208.9 USD | +3.18% | +7.47% | -19.27% |
Apr. 26 | Guggenheim Adjusts Price Target on Biogen to $255 From $275 | MT |
Apr. 25 | Biogen Inc. Receives Positive CHMP Opinion for TOFIDence (tocilizumab), a Biosimilar Referencing ROACTEMRA | CI |
Financials (USD)
Sales 2024 * | 9.52B | Sales 2025 * | 9.54B | Capitalization | 29.48B |
---|---|---|---|---|---|
Net income 2024 * | 1.89B | Net income 2025 * | 2.22B | EV / Sales 2024 * | 3.45 x |
Net Debt 2024 * | 3.38B | Net Debt 2025 * | 349M | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
15.4
x | P/E ratio 2025 * |
13.4
x | Employees | 7,570 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.22% |
Latest transcript on Biogen Inc.
1 day | +3.18% | ||
1 week | +7.47% | ||
Current month | -3.12% | ||
1 month | -1.47% | ||
3 months | -14.67% | ||
6 months | -13.35% | ||
Current year | -19.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 22-11-13 | |
Director of Finance/CFO | 60 | 20-08-14 | |
Nicole Murphy
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 09-12-31 |
William Hawkins
BRD | Director/Board Member | 70 | 19-06-18 |
Caroline Dorsa
CHM | Chairman | 64 | 10-01-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.30% | 1 M€ | 0.00% | - | |
3.92% | 0 M€ | 0.00% | - | |
3.75% | 0 M€ | 0.00% | - | |
2.39% | 14,021 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 208.9 | +3.18% | 1,893,878 |
24-04-25 | 202.5 | +0.23% | 1,590,300 |
24-04-24 | 202 | +4.56% | 3,265,676 |
24-04-23 | 193.2 | -0.48% | 1,461,694 |
24-04-22 | 194.1 | -0.14% | 1,119,536 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.27% | 29.48B | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
+57.86% | 25.43B | |
-17.69% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B | |
+2.29% | 7.67B |
- Stock Market
- Equities
- BIIB Stock